[go: up one dir, main page]

SE8300495L - IMPROVEMENTS OR IN CONNECTION WITH NASAL PHARMACEUTICAL COMPOSITIONS - Google Patents

IMPROVEMENTS OR IN CONNECTION WITH NASAL PHARMACEUTICAL COMPOSITIONS

Info

Publication number
SE8300495L
SE8300495L SE8300495A SE8300495A SE8300495L SE 8300495 L SE8300495 L SE 8300495L SE 8300495 A SE8300495 A SE 8300495A SE 8300495 A SE8300495 A SE 8300495A SE 8300495 L SE8300495 L SE 8300495L
Authority
SE
Sweden
Prior art keywords
connection
pharmaceutical compositions
nasal pharmaceutical
ciliary function
nasal
Prior art date
Application number
SE8300495A
Other languages
Swedish (sv)
Other versions
SE454402B (en
SE8300495D0 (en
Inventor
J-R Kiechel
F Acezat-Mispelter
D Plas
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8300495D0 publication Critical patent/SE8300495D0/en
Publication of SE8300495L publication Critical patent/SE8300495L/en
Publication of SE454402B publication Critical patent/SE454402B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

: A nasal pharmaceutical composition incorporates a non-toxic agent which is capable of increasing the ciliary function e.g. caffeine and at least partially antagonising the ciliary function depressant effect of the active agent e.g. dihydroergotamine or any other constituent present in the composition.
SE8300495A 1982-02-01 1983-01-31 NATIONAL ADMINISTRATIVE PHARMACEUTICAL COMPOSITION INCLUDING AN ERGOTPEPTIDALKALOID AND XANTIN SE454402B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8202781 1982-02-01

Publications (3)

Publication Number Publication Date
SE8300495D0 SE8300495D0 (en) 1983-01-31
SE8300495L true SE8300495L (en) 1983-08-02
SE454402B SE454402B (en) 1988-05-02

Family

ID=10528017

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8300495A SE454402B (en) 1982-02-01 1983-01-31 NATIONAL ADMINISTRATIVE PHARMACEUTICAL COMPOSITION INCLUDING AN ERGOTPEPTIDALKALOID AND XANTIN

Country Status (27)

Country Link
JP (1) JPS58134017A (en)
AT (1) AT385656B (en)
AU (1) AU565613B2 (en)
BE (1) BE895750A (en)
CA (1) CA1197783A (en)
CH (1) CH653555A5 (en)
DE (1) DE3302949A1 (en)
DK (1) DK164771C (en)
ES (1) ES519450A0 (en)
FI (1) FI81258C (en)
FR (1) FR2539994B1 (en)
GR (1) GR81320B (en)
HK (1) HK59989A (en)
HU (1) HU191512B (en)
IE (1) IE54532B1 (en)
IL (1) IL67822A (en)
IT (1) IT1197558B (en)
KE (1) KE3888A (en)
LU (1) LU84613A1 (en)
MY (1) MY8700766A (en)
NL (1) NL192325C (en)
NZ (1) NZ203117A (en)
PH (1) PH22198A (en)
PT (1) PT76166B (en)
SE (1) SE454402B (en)
SG (1) SG34389G (en)
ZA (1) ZA83673B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0715285D0 (en) * 2007-08-06 2007-09-12 Britannia Pharmaceuticals Ltd Improvements in or relating to powdered medicaments for nasal delivery
GB0910375D0 (en) * 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
CN111936140A (en) * 2018-01-05 2020-11-13 英倍尔药业股份有限公司 Intranasal Delivery of Dihydroergotamine via Precision Nasal Device

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3091569A (en) * 1960-08-26 1963-05-28 Mead Johnson & Co Mucolytic-nu-acylated sulfhydryl compositions and process for treating animal mucus
GB1202885A (en) * 1966-12-22 1970-08-19 Sandoz Ltd Pharmaceutical compositions comprising alkaloids
DE2750090A1 (en) * 1976-11-19 1978-06-01 Sandoz Ag NEW FORMS OF ADMINISTRATION FOR ORGANIC COMPOUNDS
FR2387035A1 (en) * 1977-04-12 1978-11-10 Cassenne Lab Sa NEW MEDICINAL PRODUCT INTENDED IN PARTICULAR FOR THE TREATMENT OF FUNCTIONAL CEREBRAL DISORDERS
DE2831728C2 (en) * 1978-07-19 1982-12-23 Krewel-Werke Gmbh, 5208 Eitorf Medicines used to treat headaches

Also Published As

Publication number Publication date
LU84613A1 (en) 1983-09-08
SE454402B (en) 1988-05-02
FI830245L (en) 1983-08-02
AU1085083A (en) 1983-08-11
IE54532B1 (en) 1989-11-08
ES8502865A1 (en) 1985-02-01
ATA30383A (en) 1987-10-15
IT8347646A1 (en) 1984-08-01
KE3888A (en) 1989-09-01
DE3302949A1 (en) 1983-08-11
NL8300325A (en) 1983-09-01
DK38183D0 (en) 1983-01-31
IT1197558B (en) 1988-12-06
FR2539994A1 (en) 1984-08-03
HK59989A (en) 1989-08-04
DK164771C (en) 1992-12-28
DK164771B (en) 1992-08-17
PT76166A (en) 1983-02-01
FI830245A0 (en) 1983-01-25
FI81258B (en) 1990-06-29
PT76166B (en) 1986-02-04
FI81258C (en) 1990-10-10
NL192325B (en) 1997-02-03
MY8700766A (en) 1987-12-31
SE8300495D0 (en) 1983-01-31
IL67822A (en) 1988-02-29
HU191512B (en) 1987-02-27
NZ203117A (en) 1986-12-05
DE3302949C2 (en) 1992-05-21
PH22198A (en) 1988-06-28
JPH0253406B2 (en) 1990-11-16
IE830187L (en) 1983-08-01
AU565613B2 (en) 1987-09-24
JPS58134017A (en) 1983-08-10
ES519450A0 (en) 1985-02-01
IT8347646A0 (en) 1983-02-01
SG34389G (en) 1989-09-22
CA1197783A (en) 1985-12-10
NL192325C (en) 1997-06-04
CH653555A5 (en) 1986-01-15
BE895750A (en) 1983-08-01
DK38183A (en) 1983-08-02
ZA83673B (en) 1984-09-26
GR81320B (en) 1984-12-11
FR2539994B1 (en) 1986-10-10
IL67822A0 (en) 1983-06-15
AT385656B (en) 1988-05-10

Similar Documents

Publication Publication Date Title
DE3484997D1 (en) CELL-stimulating agent.
ATE61050T1 (en) PYRIDAZINAMINES EFFECTIVE AGAINST VIRUSES.
NZ195517A (en) Imidazole-5-acetic acid derivatives and pharmaceutical compositions
NZ195568A (en) Guanidine derivatives and pharmaceutical compositions
MY101791A (en) New benzimidazole derivatives
SE441179B (en) NEW CYCLOPROPANCARBOXYL ACIDS WITH POLYHALOGENATED SUBSTITUENT, SET FOR PREPARATION AND USE thereof IN PESTICIDE COMPOSITIONS
DE3872635D1 (en) PENTAMIDINE CONTAINING PHARMACEUTICAL COMPOSITIONS.
IT8468241A0 (en) ACTIVE PHARMACEUTICAL TRYPTOPHAN DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
IT1205337B (en) ETHEROARYL-AMINOMETHYLENE-DERIVED DERIVATIVES SUBSTITUTED FOR REGULATORY ACTIVITY OF THE HEART RHYTHM AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM
IE781032L (en) Pharmaceutical compositions
ZA812088B (en) Derivative of saccharide and physiologically active agent containing the same
SE8504976L (en) OGONDROPAR CONTAINS BROMOCRIPTIN
NZ184678A (en) Pyrimidine derivatives and pharmaceutical compositions
FI843560A7 (en) Mevalonolactone analogues and derivatives thereof, methods for their preparation, pharmaceutical compositions containing them and their use as pharmaceutical agents.
DE3675876D1 (en) COMPETITIVE APPETIT MELTING AND AGAINST GASTRITIS.
JPS565465A (en) Benzimidazole derivative* its manufacture and medicinal composition of same as active component
NZ184766A (en) Alkylphenyl ethers and thioethers and pharmaceutical compositions
JPS5767518A (en) Radiosensitizing agent or agent for increasing effect of radiomimetic substance
SE8300495L (en) IMPROVEMENTS OR IN CONNECTION WITH NASAL PHARMACEUTICAL COMPOSITIONS
ZA773979B (en) Pharmaceutically active benzamine compounds and compositions
GB2021409A (en) Pharmaceutical composition
NZ184102A (en) Derivatives of benzenesulphonylurea,and pharmaceutical compositions
NZ185296A (en) Corticoids and pharmaceutical compositions
IT8319600A0 (en) PHARMACEUTICAL COMPOSITIONS AND THEIR USE IN THE TREATMENT OF GLAUCOMA.
IT8222911A0 (en) DERIVATIVES OF 1-METHYL-5-NITRO-IMIDAZOLINE AND THERAPEUTIC COMPOSITIONS WHICH INCLUDE THEM AS THE ACTIVE INGREDIENT.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8300495-2

Format of ref document f/p: F

NUG Patent has lapsed